Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024 PR Newswire NEW YORK, Oct. 8...
Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players PR...
American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer...
PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements PR Newswire NEW YORK, Sept. 16...
Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International...
Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health PR Newswire NEW YORK, Sept...
Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of...
The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection...
PAVmed Provides Business Update and Second Quarter 2024 Financial Results PR Newswire NEW YORK, Aug. 13, 2024...
Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results PR Newswire NEW YORK...
Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing...
Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal...
Lucid Diagnostics to Participate in Upcoming Investor Conferences PR Newswire NEW YORK, Aug. 5, 2024 NEW YORK...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관